The Correlation and Intervention of Intestinal Flora and Frailty in the Elderly
Launched by XIJING HOSPITAL · Jun 21, 2019
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
100 healthy controls, 100 pre-frailty and 100 frailty elderly will be included. the healthy controls will be received no intervention. The pre-frailty will be randomized at a 1:1 ratio to receive prebiotics (inulin) or placebo (maltodextrin) . The degree of improvements and correlation in frailty will be evaluated three months later.Similarly,the frailty also will be randomized at a 1:1 ratio to receive prebiotics (inulin) or placebo (maltodextrin). The degree of improvements and correlation in frailty will be evaluated three months later.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age ≥65 years;
- • Can get up from a chair and walk 6 meters
- • Clearly consciousness, able to read or use words to express and communicate without difficulty
- • Agree and accept the study plan
- Exclusion Criteria:
- • Acute and chronic inflammatory disease of the intestine within 3 months
- • Use of antibiotics, probiotics, prebiotics or synthetics, laxatives or diarrhea medications, proton pump inhibitors or gastric motility drugs within 1 month
- • Dementia
- • mental illness or blindness
- • acute infection
- • cancer
About Xijing Hospital
Xijing Hospital, a prominent medical institution affiliated with the Fourth Military Medical University in Xi'an, China, is dedicated to advancing healthcare through innovative clinical research. Renowned for its comprehensive range of medical services and expertise in various specialties, Xijing Hospital actively sponsors clinical trials aimed at evaluating new therapies, improving patient outcomes, and contributing to scientific knowledge. With a commitment to ethical standards and patient safety, the hospital fosters collaboration among multidisciplinary teams to drive forward the development of effective treatment options that address critical health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Xi'an, Shaanxi, China
Patients applied
Trial Officials
Wang xiao ming
Study Chair
Director of geriatrics
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials